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Abstract
Background: Artemin (ARTN) is a neurotrophic factor belonging to the glial cell-derived neurotrophic factor family
of ligands. To develop potential therapy targeting ARTN, we studied the roles of miR-223 in the migration and
invasion of human esophageal carcinoma.
Methods: ARTN expression levels were detected in esophageal carcinoma cell lines KYSE-150, KYSE-510, EC-9706,
TE13, esophageal cancer tissues and paired non-cancerous tissues by Western blot. Artemin siRNA expression
vectors were constructed to knockdown of artemin expression mitigated migration and invasiveness in KYSE150
cells. Monolayer wound healing assay and Transwell invasion assay were applied to observe cancer cell migration
and invasion. The relative levels of expression were quantified by real-time quantitative PCR.
Results: ARTN expression levels were higher in esophageal carcinoma tissue than in the adjacent tissue and was
differentially expressed in various esophageal carcinoma cell lines. ARTN mRNA contains a binding site for miR-223
in the 3’UTR. Co-transfection of a mir-223 expression vector with pMIR-ARTN led to the reduced activity of
luciferase in a dual-luciferase reporter gene assay, suggesting that ARTN is a target gene of miR-223.
Overexpression of miR-223 decreased expression of ARTN in KYSE150 cells while silencing miR-223 increased
expression of ARTN in EC9706 cells. Furthermore, overexpression of miR-223 in KYSE150 cells decreased cell
migration and invasion. Silencing of miR-223 in EC9706 cells increased cell migration and invasiveness.
Conclusions: These results reveal that ARTN, a known tumor metastasis-related gene, is a direct target of miR-223 and
that miR-223 may have a tumor suppressor function in esophageal carcinoma and could be used in anticancer
therapies.
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Background
Artemin (ARTN) is a neurotrophic factor belonging to the
glial cell-derived neurotrophic factor (GDNF) family of
ligands (GFLs) [1-4], which is important in tumor growth,
migration, adhesion and invasion [5,6]. Increased expres-
sion of ARTN has been identified in several human can-
cers including breast cancer, pancreatic cancer, thyroid
carcinoma and endometrial carcinoma [5-10]. Increasing
evidence had demonstrated a connection between high
expression of ARTN and tumor relapse, metastasis and
poor prognosis [7,8].
MicroRNAs (miRNAs) are a group of small non-cod-
ing RNAs (approximately 21-25 nt) that negatively regu-
late gene expression by imprecisely binding to
complementary sequences in the 3’ untranslated region
(UTR) of their target mRNAs [11,12]. It has been con-
firmed that miRNA abnormalities play an important
role in gene regulation, apoptosis, the maintenance of
cell differentiation and tumorigenesis [13-15]. A recent
study has shown that differential expression of miRNAs
was correlated with esophageal carcinoma survival
[16,17]. Furthermore, down-regulation of miR-223 was
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leukemia [18,19]. There is emerging evidence that sug-
gests that miR-223 plays an important role in cell prolif-
eration, hematopoietic development and differentiation
[20-22]. In this study, we discovered that the expression
of ARTN in esophageal carcinoma tissue was higher
than that of adjacent tissues, and down-regulation of
artemin expression mitigated KYSE150 cell migration
and invasiveness. Furthermore, ARTN is a target gene
of miR-223. Regulation of miR-223 expression affected
t h ee x p r e s s i o no fA R T Na sw e l la sc e l lm i g r a t i o na n d
invasion in esophageal carcinoma cells. Finally, we vali-
dated that ARTN is a direct target of miR-223 in the
context of human esophageal carcinoma.
Methods
Cell culture
The human esophageal carcinoma cell lines KYSE-150,
KYSE-510, EC-9706 and TE13 were cultured in RPMI-
1640 (Invitrogen, Carlsbad, CA) medium supplemented
with 10% fetal bovine serum (FBS, GIBCO), 100 IU/ml
penicillin and 100 mg/ml streptomycin in humidified 5%
CO2 at 37°C. Human embryonic kidney 293 (HEK293)
cells were cultured in Dulbecco’s minimum essential
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, and 1 mM sodium
pyruvate. For transfection, cells were grown to 80% con-
fluency and transfected with RNAi vector, recombined
eukaryotic vector, a chemically synthesized miRNA-223
inhibitor or a negative control using Lipofectamine 2000
(Invitrogen, CA, USA), according to the manufacturer’s
recommendation.
Collection of tissues
Three samples of esophageal cancer tissues and paired
non-cancerous tissues (5 cm away from tumor) were
obtained from The Second Hospital of He Bei Medical
University. The tissue samples were collected with writ-
ten consent from the patients. The resected tissue sam-
ples were immediately cut into small pieces and snap
frozen in liquid nitrogen until use. All tumor tissue and
paired non-cancerous tissue samples were pathologically
confirmed.
Western blot analysis
Purified esophageal cancer antigen in cold lysate buffer
(50 mmol/L Tris-Cl pH 8.0, 150 mmol/L NaCl, 10
mmol/L Triton X-100, 10 mmol/L PMSF) was separated
on 10% gradient SDS-polyacrylamide gels in the pre-
sence of b-mercaptoethanol. The proteins were trans-
ferred onto a NC membrane, blocked with 50 mg/mL
fat-free milk in 100 ml PBS for 2 h and incubated with
the primary antibody (anti-artemin, R&D Systems) over-
night at 4°C. The membrane was washed and then
i n c u b a t e dw i t hH R P - c o n j u g a t e dg o a ta n t i - r a tI g G / I g M
(Sigma-Aldrich) at RT for 1 h. The membrane was
washed again, and the antigen-antibody reaction was
visualized using an ECL detection system. The band
intensity was quantified by arithmetic analysis using the
software Scion Image beta 4.03. The ratio of artemin/b-
actin in each sample was used for statistical analysis.
Construction of artemin siRNA expression vectors
To knock down artemin expression, we used a pSilencer
2.1 vector encoding a small hairpin RNA directed
against the target gene in KYSE-150 cells. The target
sequence for artemin was 5’- AACAGCACCTGGA-
GAACCGTG -3’ (KYSE-150/RNAi). As a negative con-
trol, we used an shRNA vector without the hairpin
oligonucleotides (KYSE-150/NC).
Monolayer wound healing assay
Migration ability was determined using a wound-healing
assay. Cells were grown in 10% FBS medium on 60 mm
plates. After the cells reached sub-confluence, the cells
were wounded by scraping the monolayer and grown in
medium for 48 h. The width of the wound was mea-
sured at different time points. Three to four different
locations were visualized and photographed under a
phase-contrast inverted microscope (40× objective,
Leica, Solms, Germany).
Transwell invasion assay
Cell invasion assays were performed using 24-well trans-
wells (8 mm pore size, Corning Life Sciences) coated
with matrigel (1 mg/ml, BD Sciences). Cells (10
4/well)
were seeded in the upper chambers of the wells in 200
μl FBS-free medium, and the lower chambers were filled
with 500 μl 10% FBS medium to induce cell migration.
Following incubation for 24 h, the cells on the filter sur-
face were fixed with 4% formaldehyde, stained with 0.5%
crystal violet, and examined under a microscope. Cells
in at least six random microscopic fields (200×) were
counted.
Plasmid construction and luciferase reporter assay
The eukaryotic expression vector pcDNA3.1 (+) (Invi-
trogen) was used to construct the miRNA expression
plasmid. The genomic sequences, including 200 bp
flanking sequences, of the human miR-105, miR-223
and miR-760 genes were cloned from HEK293 cells.
The PCR products were digested by EcoR I and BamH I
and subcloned into the pcDNA3.1 (+) vector. The full-
length 3’ untranslated region (3’UTR) of ARTN was
amplified from a human cDNA library; the amplified
product (464 bp) was subcloned into the pMIR-GLO™
luciferase vector (pMIR, Invitrogen) downstream of the
firefly luciferase coding region. The recombined vector
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sites were introduced by site-directed mutagenesis; four
nucleotides within the core binding sites of ARTN
3’UTR were changed. The resulting vector was called
pMIR-ARTN-Mut. Primer sequences used in construc-
tion of the vectors are listed in Table 1. The sequences
of the resulting reporter vectors were verified by
sequence analysis.
Luciferase assays were conducted using 1 × 10
4 HEK
293 cells plated on a 96-well plate. Co-transfection was
performed using 2 ng pMIR-ARTN, pMIR-ARTN-Mut
or pMIR-GLO™ empty vector and either 80 ng miRNA
expression vector or pcDNA 3.1(+) empty vector. Forty-
eight hours after transfection, the cells were harvested
and assayed for both firefly and renilla luciferase using
the dual-luciferase glow assay (Promega, Madison, WI).
All transfection experiments were conducted in
triplicate.
Real-time quantitative PCR
Quantitative RT-PCR was carried out using SYBR Pre-
m i xE xT a q ™ (Code DRR041A, Takara). Total RNA
isolated using the mirVana Kit (Applied Biosystems,
CA) was subsequently reverse transcribed to cDNA
using the stem-loop reverse transcription primer for
miRNA detection. Reverse transcription of ARTN
mRNA was performed using M-MLV reverse transcrip-
tase (Epicentre, Paris, France) and a random primer.
The U6 small nuclear RNA and GAPDH mRNA were
used as internal controls for miRNA and ARTN mRNA,
respectively. All primer sequences are listed in Table 2.
The reactions were placed in a 96-well plate (ABI) using
a preheated real-time instrument (ABI 7500 HT). The
relative levels of expression were quantified and ana-
lyzed using Bio-Rad iCycler iQ software. Ct values were
used to calculate the levels of RNA expression. The
amount of target gene expression (2
-ΔΔCt) was normal-
ized using the endogenous GAPDH or U6 reference; the
amount of target gene in the control sample was set at
1.0.
MTT assay
Cells (1.0 × 10
4 cells/ml) were cultured in 96-well plates
for varying periods of time and exposed to fresh media
every other day. During the last 4 h of each day of cul-
ture, the cells were treated with methyl thiazolyl tetrazo-
lium (MTT, 50 μg per well, Sigma, USA). The generated
formazan was dissolved in DMSO, and the absorbance
at 570 nm was measured to measure cell viability.
Statistical analysis
Data are expressed as mean ± SEM. The difference
among groups was determined by ANOVA analysis and
comparison between two groups was analyzed by the
Student’s t-test using GraphPad Prism software version
4 . 0( G r a p h P a dS o f t w a r e ,I n c . ,S a nD i e g o ,C A ) .Av a l u e
of P < 0.05 was considered statistically significant.
Results
Expression of ARTN in human esophageal carcinoma
tissues and cell lines
To explore the role of ARTN in esophageal cancer, the
expression level of ARTN in human esophageal carci-
noma and normal tissues was detected by Western blot
and quantified by densitometry using b-actin as a load-
ing control. In most cases, ARTN levels in normal eso-
phageal tissue were significantly lower than those in
esophageal cancer tissue (Figure 1A). The expression
level of ARTN in four human esophageal carcinoma cell
lines was also examined by Western blot. As seen in
Figure 1B, all four carcinoma cell lines expressed
ARTN. The highest expression was detected in
KYSE150 cells, while moderate expression was observed
in the KYSE510 and TE13 cell lines, and low expression
was observed in EC9706 cells.
Effect of down-regulated artemin expression on the
migration of KYSE150 cells
Overexpression of an oncogene is crucial for the devel-
opment of tumors as it can promote strong invasion of
tumor cells. To determine the impact of artemin
Table 1 Primer sequences of expression vectors construction
Gene name Primer name primer sequence
miR-223 sense primer 5’-TGGATCCGTGTCACTCGGGCTTTACCTG-3’
antisense primer 5’- CGAATTCGTAGACACAGCCCAGGGCTGT-3’
miR-105 sense primer 5’-TGGATCCGTGCTTATGCCCTTTAGCTATG-3’
antisense primer 5’- TGAATTCCTGATGGTGCCATGCTTCCTCATATG-3’
mir-760 sense primer 5’-TGGATCCGAGCGCGCGCCCTCCGACCAC-3’
antisense primer 5’-TGAATTCCCGTTAAGCCGGGCCGGTGAC-3’
ARTN-3’UTR sense primer 5’- TGAGCTCGGGCTCGCTCCAGGGCTTTGCAGAC-3’
antisense primer 5’- TCTCGAGATAGGGGCCAGCTCCCATGAGTG-3’
ARTN-3’UTR-Mut sense primer 5’-AAGACTCTAGCAGCCCCAGAGCCCTCAC-3’
antisense primer 5’-GTCCCTTCACCTGTTCGGGGATGA-3’
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structed siRNA expression vectors (KYSE150/RNAi)
specific to artemin transcripts and transfected them into
KYSE150 cells. The knockdown was confirmed by wes-
tern blot; KYSE150/RNAi was effective compared to the
negative control (KYSE150/NC) and the parental
KYSE150 cells [Figure 2(A, B)]. The successful knock-
down of the artemin gene in KYSE150 cells provided a
useful tool for investigating the function of ARTN in
the growth of KYSE150 cells.
Next, we examined the impact of artemin expression
on the migration of KYSE150 cells by a wound healing
assay, shown in Figure 2(C). Following incubation of
physically-wounded cells for 48 h, KYSE150/RNAi cells
had traveled a significantly shorter distance than control
cells [Figure 2(D)]. To analyze invasiveness, another
important feature of malignant cells, we performed
transwell invasion assays using cell culture inserts cov-
ered with extracellular matrix components. KYSE150
and KYSE150/NC cells had strong invasive abilities
while inhibition of artemin resulted in a massive reduc-
tion in invasion (Figure 2E and 2F). The wound healing
and invasion assays indicate that down-regulation of
artemin expression reduces the migration of KYSE150
cells.
miR-223 interacts with the ARTN 3’UTR and regulates
endogenous ARTN protein expression
To identify potential miRNAs that specifically target and
regulate ARTN, we used bioinformatic web-based
Table 2 Primer sequences of products expression
Gene name Primer name primer sequence
U6 RT primer 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAAATATGGAAC-3’
sense primer 5’-TGC GGGTGCTCGCTTCGGCAGC-3’
antisense primer 5’-CAGTGCAGGGTCCGAGGT-3’
GAPDH RT primer radom primer
sense primer 5’-TGGGTGTGAACCACGAGAA-3’
antisense primer 5’-GGCATGGACTGTGGTCATGA-3’
miR-223 RT primer 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTGGGGT-3’
sense primer 5’-CGTTGTCAGTTTGTCAAATAC-3’
antisense primer 5’-CAGTGCAGGGTCCGAGGT-3’
ARTN RT primer radom primer
sense primer 5’-TGCTGAGCAGCGTCGCAGAG-3’
antisense primer 5’-GCTCTTCCACTGCACCAGCG-3’
Figure 1 ARTN expression in esophageal carcinoma tissues and cells. (A) ARTN expression in esophageal carcinoma and normal tissues
using Western blot (upper panel). Bar graph of the relative expression of ARTN in tissues relative to control b-actin (lower panel). (B) ARTN
expression in esophageal carcinoma cells (KYSE150, KYSE510, TE13 and EC9706) (upper panel). Bar graph of the relative expression of ARTN in
cells; ARTN(KYSE150) was set as control (lower panel). Data are representative of each group or expressed as mean ± SEM from three separate
experiments.
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scan the 3’UTR of ARTN for miRNAs binding sites. As
a result, the three miRNAs with the highest free energy
(hsa-mir-105, hsa-mir-223 and hsa-mir-760) were cho-
sen. The seed regions for the three miRNAs for the
ARTN 3’UTR are shown in Additional file 1, Figure
S1A.
In order to clarify which miRNA is capable of regulat-
ing ARTN protein expression via binding to the 3’UTR
of ARTN, we cloned the full length ARTN 3’UTR from
a cDNA library downstream of the firefly luciferase cod-
ing region in pMIR-GLOTM luciferase vector. We also
made mutations to the putative binding site (Additional
file 1, Figure S1B). miR-105, miR-223 and miR-760
including a 200 bp flanking sequence were cloned from
human genomic DNA and inserted into pcDNA3.1 (+)
multiple cloning sites to construct the miRNAs
expression vectors. The human embryonic kidney cell
line 293 (HEK293) was used for the reporter assay.
HEK293 cells were cultured and transfected with pMIR-
ARTN and miRNA expression vector or pcDNA3.1 (+)
empty vector. After 48 h, the cells were harvested, and
the protein was extracted for the luciferase assay. The
miR-223 expression vector pcDNA3.1 (+)-miR-223
reduced the firefly luciferase activity (Figure 3A). Subse-
quently, transfections were carried out in HEK293 cells
with pMIR-ARTN and pcDNA3.1(+)-miR-223 or pMIR-
ARTN-Mut and pcDNA3.1(+)-miR-223. Mutation of the
binding site abolished the ability of miR-223 to inhibit
the expression of the luciferase reporter (Figure 3B).
To further study the potential relationship between
miR-223 and ARTN, we analyzed miR-223 and ARTN
expression level in esophageal cancer tissues. The nega-
tive correlation of miR-223 and ARTN expression was
Figure 2 Effect of down-regulation of ARTN on the migration of KYSE150 cells. (A) Western blotting confirmed the knockdown of artemin
expression in KYSE150 cells. (B) Bar graph of the relative expression of artemin. (C) KYSE150 cells after wounding and during healing. (D)
Measurement of migration distance. (E) The filters were stained with crystal violet and inspected under a microscope. (F) Quantitative
measurement of invaded cells. Scale bars in microscope is 100 μm. Data are representative of each group or expressed as mean ± SEM from
three separate experiments.
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sion level in four esophageal squamous cell lines
(KYSE150, KYSE510, TE13 and EC9706). High expres-
sion of miR-223 was detected in KYSE150 and
KYST510 cell lines, while low expression of miR-223
was detected in EC9706 and TE13 cell lines (Figure 3D).
Interestingly, ARTN expression levels were higher in
KYSE150 and KYSE510 than in EC9706 and TE13 cell
lines, suggesting that expression of miR-223 was inver-
sely related to ARTN protein level in esophageal carci-
noma. KYSE150 and EC9706 were used as models to
further investigate the function of miR-223 in esopha-
geal squamous cell carcinoma. We transfected
pcDNA3.1 (+)-miR-223 and pcDNA3.1 (+) empty vector
into KYSE150 cells and observed a decrease of ARTN
protein level in the presence if miR-223 (Figure 3E).
Consistent with this result, silencing of miR-223 using
an miR-223 inhibitor resulted in an increase of ARTN
protein level in EC9706 cells (Figure 3F). These results
indicate that ARTN is post-transcriptionally regulated
by miR-223.
Effect of mir-223 on the migration of esophageal
carcinoma cells
The MTT assay was used to study cell proliferation.
KYSE150 cells were transfected with pcDNA3.1 (+) or
pcDNA3.1 (+)-miR-223 prior to the proliferation assy.
The overexpression of mir-223 did not inhibit prolifera-
tion of KYSE150 cells. The morphology of KYSE150
cells transfected with either pcDNA3.1 (+) or pcDNA3.1
(+)-miR-223 did not change compared to the untreated
group, and no difference in cell viability between the
three groups was observed (Additional file 2, Figure
S2A). In EC9706 cells, the morphology and proliferation
did not change when the cells were transfected with a
mir-223 inhibitor or Scr-miR-223. (Additional file 2, Fig-
u r eS 2 B ) .T h eM T Ta s s a yd e m onstrates that miR-223
does not significantly influence the proliferation of eso-
phageal carcinoma cells.
Scratch-wound healing assays were used to evaluate
the effect of miR-223 on cell migration. To explore the
potential role of miR-223 in the migration of esophageal
carcinoma cell lines, we first examined the effect of the
Figure 3 miR-223 interacts with the ARTN 3’UTR and regulates endogenous ARTN protein expression. (A) The miR-223 expression vector
pcDNA3.1 (+)-miR-223 reduced the activity of firefly luciferase. (B) Mutation of the binding site abolished the ability of miR-223 to inhibit the
expression of the luciferase reporter. (C) The relative expression of miR-223 and artemin mRNA in esophageal carcinoma tissues. (D) The relative
expression of miR-223 and artemin in esophageal carcinoma cells (KYSE150, KYSE510, TE13 and EC9706). (E) miR-223 inhibitor enhanced the
expression of ARTN in EC9706 cells. (F) Overexpression of miR-223 reduced the expression of ARTN in KYSE150 cells. Data are representatives of
each group or expressed as mean ± SEM of from three separate experiments.
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very low levels of endogenous miR-223, on cell migra-
tion. KYSE150 cells transfected with pcDNA3.1
(+)-miR-223 closed the scratch-wounds more slowly
than cells that were untreated or transfected with
pcDNA3.1 (+) (Figure 4A, B). Meanwhile, EC9706 cells
transfected with either an miR-223 inhibitor or Scr-
miR-223 closed the scratch-wounds more quickly than
cells that were untreated or transfected with pcDNA3.1
(+) (Figure 4C, D).
To examine invasion, KYSE150 cells were transfected
with either pcDNA3.1 (+)-miR-223 or pcDNA3.1 (+)
and reseeded on top of the insert. Consistent with the
migration results, overexpression of miR-223 signifi-
cantly inhibited invasion of KYSE150 cells (Figure 4E,
F). EC9706 cells, which have a high level of endogenous
miR-223, were transfected with an miR-223 inhibitor or
a negative control. The EC9706 cells transfected with
the miR-223 inhibitor could effectively penetrate the
chamber and travel to the other side of the membrane
(Figure 4G, H). Matrix metalloproteinases (MMPs) com-
prise a family of secreted or membrane-associated zinc-
dependent extracellular endopeptidases that enhance
invasion and metastases. To determine if increased inva-
sion observed was associated with concomitant change
of MMP levels, expression of MMP-2 and MMP-9 were
performed. MMP-2 and MMP-9 levels were decreased
following up-regulation of miR-223, whereas MMP-2
and MMP-9 levels were increased by inhibition of miR-
223 (Figure 4I, G). These observations indicate that
Figure 4 Effect of miR-223 expression on migration in esophageal carcinoma cells. (A, B) KYSE150 cells after wounding and during healing.
(C, D) The filters were stained with crystal violet and inspected under a microscope (KYSE150 cells). (E, F) The filters were stained with crystal
violet and inspected under a microscope (EC9706 cells). (G, H)EC9706 cells after wounding and during healing. (scale bars, 100 μm). (I, J) The
expression of mmp2 and mmp9. Scale bars in microscope is 100 μm. Data are representative of each group or expressed as mean ± SEM from
three separate experiments.
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cinoma cell lines.
Discussion
Tumor metastasis is a complex multistep process
including cell adhesion, migration, angiogenesis,
immune escape, and homing to target organs. Cell moti-
lity, invasion and invasion are essential features of the
metastatic process. Identifying the molecules and path-
ways that control cell motility and invasion is critical to
understanding cancer metastasis. Accumulating evidence
is suggesting that ARTN is involved in cancer metasta-
sis. ARTN has been shown to promote cell migration
and invasion in human endometrial cell line [8]. In addi-
tion, depletion of ARTN can inhibit breast cancer
metastasis in vivo [5]. Consistent with these results,
ARTN overexpression induces cell migration and inva-
sion in pancreatic cancer cells [6,7]. These observations,
taken together, indicate that ARTN plays a positive role
in migration and invasion of cancer cells. In the present
study, we demonstrate that ARTN expression is signifi-
cantly higher in esophageal carcinoma than in adjacent
noninvasive tissues, and that ARTN promotes migration
and invasion of esophageal carcinoma cells.
Recently, emerging evidence has implicated miRNAs
in metastasis of human cancer. To verify whether
ARTN expression is regulated by miRNAs, miR-105,
miR-223 and miR-760 were chosen for further study
according to the results of a bioinformatic search. We
found that miR-223 interacts with the ARTN 3’UTR
and regulates endogenous ARTN protein expression.
miR-223 was found to be downregulated in breast and
ovarian cancer specimens compared to normal ovarian
tissues [23]. Down-regulation of miR-223 has in vivo
significance in chronic lymphocytic leukemia and
improves disease risk stratification [19]. In the present
study, overexpression of miR-223 leads to a decrease in
ARTN function and represses cellular migration and
invasion in KYSE150 cells. On the contrary, silencing of
miR-223 increases ARTN expression and promotes cel-
lular migration and invasion in EC9706 cells.
Conclusions
In conclusion, ARTN expression levels were significantly
higher in esophageal carcinoma than in adjacent nonin-
vasive tissues, and ARTN promoted migration and inva-
sion of esophageal carcinoma cells. Furthermore, ARTN
mRNA was a direct and functional target of miR-223.
Finally, we revealed that miR-223 overexpression
repressed cell migration and invasion in human esopha-
geal carcinoma cell lines. We provided strong evidence
that supports a role for ARTN in tumor cell migration
and invasion. Future studies should examine how miR-
223 is regulated in human cancer and other human
diseases and whether both ARTN and miR-223 are tar-
gets for therapy.
Additional material
Additional file 1: Figure S1. The miRNA binding sites in ARTN. (A)
The location of seed sites for miR-105, miR-223 and miR-760 within the
ARTN 3’UTR. The three binding sites are highly conserved among species.
(B) Construction of the firefly luciferase reporter gene for ARTN. Mutation
sites are shown.
Additional file 2: Figure S2. miR-223 has no effect on the
proliferation of esophageal carcinoma cells. (A) Proliferation assay in
KYSE150 cells using MTT. (B) Proliferation assay in EC9706 cells.
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